Pursuant to the Regulation 30 of the SEBI Listing Regulations, Solara Active Pharma Sciences has informed that it enclosed a copy of the Press Release on unaudited Financial Results for the 1st Quarter Ended June 30, 2025. The same will also be made available on the website of the Company https://solara.co.in/investor-relations/investor-update/. The Press Release (along with Earnings Presentation) for the Board Meeting held on July 25, 2025 issued by the Company titled: ‘Solara Q1’26 performance’.
The above information is a part of company’s filings submitted to BSE.
